The Use of Double Test Biomarkers to Predict Fetal Nuchal Translucency Thickness in the Diagnosis of Trisomy 21: A Compromise Between Sensitivity and Specificity. Cent Asian J Med Sci 2018, 4 (3), 230-237. https://doi.org/10.24079/cajms.2018.09.009.